GlassScriptPhysician profile
Chad C Lunt
NPI 1396790309
$1,608.72
in general payments reported to CMS, 2019-2025
22 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $69.21 · 2021: $381 · 2022: $398 · 2023: $129 · 2024: $213 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $609.32 | 2019-2023 | |
| Biogen, INC. | $162.53 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $98.72 | 2021-2022 | |
| Therapeuticsmd, INC. | $97.67 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $78.11 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $78.07 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.04 | 2019-2022 | |
| Coloplast Corp | $63.47 | 2022 | |
| Astellas Pharma US INC | $53.38 | 2024 | Veozah |
| Medical Device Business Services, INC. | $52.20 | 2021 | |
| Ethicon US, LLC | $33.40 | 2022 | |
| Convatec INC. | $32.75 | 2022 | |
| Hologic Sales and Service, LLC | $30.89 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $20.76 | 2024 | Bd Onclarity |
| Daiichi Sankyo INC. | $19.48 | 2024 | Injectafer |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $19.43 | 2022 | |
| Organon LLC | $18.82 | 2024 | |
| Becton, Dickinson and Company | $17.68 | 2022 | |
| Amarin Pharma, INC. | $17.58 | 2020 | |
| Dexcom, INC. | $15.73 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $12.60 | 2021 | |
| Myovant Sciences INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Lunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.